International collaboration provides access to research investments made by other leading
nations. Collaborative research is often highly innovative and has exceptional impact. The UK has had strong
links with the USA and European countries, where there is a shared culture or language. The compass of research
and innovation is swinging more and more strongly to the east. Serendipity is not enough to address all the
opportunities and will be wholly inadequate for the UK’s key interface with India and with China, the fastest
growing science and technology-base economies in the world. There is a need to analyze the UK’s present links
to its new partners to understand how collaboration with China works and to establish models of good practice.

The arteannuin is an antimalarial drug that was developed independently by scientists of China.
This type of compounds has become the first choice for the malaria. However, the enterprise of China is in the
bottom of the industry chain carries in the enormous and international market. This paper analyzed the reasons
of Chinese arteannuin enterprise lacking the market competitive advantage from the patent-protecting angle
and gave some problem-solving suggestions.

Based on data from Thomson’ s Web of Science database, the paper has analyzed the Chinese
share of science and technology papers and international co-authoring relationships. This paper then describes
the current status of industrialization of basic research in China, and discusses the possibility of future
technical cooperation between Japan and China, taking into account discussions held at the Japan-China Energy
Conservation Forum in Tokyo. In the end, the paper talks about the concrete projects, such as establishing a
model research laboratory or implementation of inter-governmental communication concerning energyconservation
policies.